Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model.
Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model.
复制标题
DOI:
10.1038/s41598-017-14815-w
复制
发表时间:
2017-11-06
影响因子:
4.6
通讯作者:
Andersson TB
中科院分区:
文献类型:
--
作者:
Bauer S;Wennberg Huldt C;Kanebratt KP;Durieux I;Gunne D;Andersson S;Ewart L;Haynes WG;Maschmeyer I;Winter A;Ämmälä C;Marx U;Andersson TB
Human in vitro physiological models studying disease and drug treatment effects are urgently needed as more relevant tools to identify new drug targets and therapies. We have developed a human microfluidic two-organ-chip model to study pancreatic islet–liver cross-talk based on insulin and glucose regulation. We have established a robust co-culture of human pancreatic islet microtissues and liver spheroids maintaining functional responses up to 15 days in an insulin-free medium. Functional coupling, demonstrated by insulin released from the islet microtissues in response to a glucose load applied in glucose tolerance tests on different days, promoted glucose uptake by the liver spheroids. Co-cultures maintained postprandial glucose concentrations in the circulation whereas glucose levels remained elevated in both single cultures. Thus, insulin secreted into the circulation stimulated glucose uptake by the liver spheroids, while the latter, in the absence of insulin, did not consume glucose as efficiently. As the glucose concentration fell, insulin secretion subsided, demonstrating a functional feedback loop between the liver and the insulin-secreting islet microtissues. Finally, inter-laboratory validation verified robustness and reproducibility. Further development of this model using tools inducing impaired glucose regulation should provide a unique in vitro system emulating human type 2 diabetes mellitus.
登录
查看更多内容
DOI:
10.1016/j.ejpb.2015.03.002
发表时间:
2015-09
期刊:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
影响因子:
--
作者:
Maschmeyer I;Hasenberg T;Jaenicke A;Lindner M;Lorenz AK;Zech J;Garbe LA;Sonntag F;Hayden P;Ayehunie S;Lauster R;Marx U;Materne EM
通讯作者:
Materne EM
DOI:
10.1038/nrd4539
发表时间:
2015-04
期刊:
Nature reviews. Drug discovery
影响因子:
--
作者:
Esch EW;Bahinski A;Huh D
通讯作者:
Huh D
DOI:
10.14573/altex.1603161
发表时间:
2016
期刊:
ALTEX
影响因子:
--
作者:
Marx U;Andersson TB;Bahinski A;Beilmann M;Beken S;Cassee FR;Cirit M;Daneshian M;Fitzpatrick S;Frey O;Gaertner C;Giese C;Griffith L;Hartung T;Heringa MB;Hoeng J;de Jong WH;Kojima H;Kuehnl J;Leist M;Luch A;Maschmeyer I;Sakharov D;Sips AJ;Steger-Hartmann T;Tagle DA;Tonevitsky A;Tralau T;Tsyb S;van de Stolpe A;Vandebriel R;Vulto P;Wang J;Wiest J;Rodenburg M;Roth A
通讯作者:
Roth A
影响因子:
3.8
作者:
Gunness, Patrina;Mueller, Daniel;Noor, Fozia
通讯作者:
Noor, Fozia
DOI:
10.1126/science.1188302
发表时间:
2010-06-25
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Huh D;Matthews BD;Mammoto A;Montoya-Zavala M;Hsin HY;Ingber DE
通讯作者:
Ingber DE